NCT06102291

Brief Summary

This is a non-inferiority randomized controlled trial, recruiting 150 patients with chronic non-specific low back pain. The patients will be randomly assigned either to Yanqing Zhitong Ointment acupoint application group (Treatment Group) or the acupuncture group (Control Group) in a 1:1 ratio.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
2mo left

Started Jul 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Jul 2022Jun 2026

Study Start

First participant enrolled

July 1, 2022

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

October 22, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 26, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

May 21, 2025

Status Verified

May 1, 2025

Enrollment Period

3.8 years

First QC Date

October 22, 2023

Last Update Submit

May 18, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • McGill pain questionnaire

    MPQ is a multi-factor pain score scale, which establishes a three-dimensional structure of the nature of pain. MPQ has a higher evaluation dimension and can evaluate the multi-dimensional factors of pain. The higher the score, the more severe the pain.

    Change from baseline to Week 4

Secondary Outcomes (4)

  • McGill pain questionnaire

    Change from baseline to Week 8 (follow-up)

  • Oswestry Dysfunction Index (ODI)

    Change from baseline to Week 4 and Week 8

  • Item Short Form Health Survey (SF-36)

    Change from baseline to Week 4 and Week 8

  • Tenderness threshold

    Change from baseline to Week 4 and Week 8

Study Arms (2)

Acupoint application with Yanqing Zhitong Ointment

EXPERIMENTAL

Acupoint selection: Ashi points, Shenshu (BL23), Guanyuanshu (BL26) Operation: Stick to each acupoint for about 4 hours. If there is a burning sensation or obvious itching or other discomfort on the part after application, it can be removed in advance. Treatment Duration: Three times a week( Monday, Wednesday, and Friday), for four weeks

Other: Yanqing Zhitong Ointment Acupoint application

Acupuncture

ACTIVE COMPARATOR

Acupoint selection: Ashi points, Shenshu (BL23), Guanyuanshu (BL26) Operation: Disposable stainless steel needles (0.25mm×25mm) are used. The needles are retained for 20 mins afte Deqi. Treatment Duration: Three times a week( Monday, Wednesday, and Friday), for four weeks

Other: Acupuncture

Interventions

Yanqing Zhitong Ointment is a traditional external preparation of experiential prescription, which is an extract made by water extraction and concentration of Qingfengteng, Corydalis yanhusuo, Interleukin, Kansui, Asarum, etc. Clinical studies in the past ten years have preliminarily shown that it has the effects of warming meridians, promoting blood circulation, dredging collaterals and relieving pain, and has a definite effect.

Acupoint application with Yanqing Zhitong Ointment

The main acupoints are Ashi points, Shenshu (BL23), Guanyuanshu (BL26). There are three sessions per week with each session lasting for 20 min. There will be 4 weeks of treatment for each participant in total.

Acupuncture

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with non-specific low back pain
  • Aage from 18 to 65
  • VAS between 4 and 7
  • No other treatment in the past 3 months
  • No other simultaneous relevant treatment
  • Voluntarily joining this study with informed consents

You may not qualify if:

  • Pregnant women
  • With skin ulcers or contusion wounds
  • Past history of severe allergy to transdermal preparations
  • Complicated with serious diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Longhua Hospital, Shanghai University of Traditional Chinese Medicine

Shanghai, 200032, China

Location

Related Publications (2)

  • Qaseem A, Wilt TJ, McLean RM, Forciea MA; Clinical Guidelines Committee of the American College of Physicians; Denberg TD, Barry MJ, Boyd C, Chow RD, Fitterman N, Harris RP, Humphrey LL, Vijan S. Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2017 Apr 4;166(7):514-530. doi: 10.7326/M16-2367. Epub 2017 Feb 14.

    PMID: 28192789BACKGROUND
  • Wen BL, Liu BY, Jin P, Wang XF, Xiang XX, Liu XF, Hu JQ, Lu F, He LY, Zhu WZ, Fang YG, Wang Y. Clinical research of acupoint application for "treatment of winter disease in summer" used to prevent and treat bronchial asthma in children. J Tradit Chin Med. 2012 Mar;32(1):31-9.

    PMID: 22594099BACKGROUND

MeSH Terms

Interventions

Acupuncture Therapy

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Yijun Zhan

    Shanghai University of Traditional Chinese Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Shanghai University of Traditional Chinese Medicine

Study Record Dates

First Submitted

October 22, 2023

First Posted

October 26, 2023

Study Start

July 1, 2022

Primary Completion

April 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

May 21, 2025

Record last verified: 2025-05

Locations